The proposed partnership between Morehouse School of Medicine (MSM), Tuskegee University (TU) and the DAB Comprehensive Cancer Center (UABCCC) builds upon an existing partnership between these 3 institutions. Each institution brings to the table a unique set of strengths that effectively supplement the inherent weaknesses of the others. It is also worth noting that the Partnership is geographically located within the heart of the Southeast, a region with a large, historically underserved, African-American population. With this partnership ultimately existing to make a significant contribution to the elimination of the gap in cancer incidence, morbidity, and mortality between Whites and Blacks, the demographics of the available study population is highly relevant. The partnership's first objective is the establishment of an effective cancer research program at MSM and TU and developing a pipeline of prospective minority investigators at TU. One way to address this objective is through an effective Research Training and Career Development (RTCD) Program. Our program would continue to tap the pool of talented faculty and students currently at MSM and TU and link them to established investigators and research infrastructure at the UABCCC. A second way to address this priority is through our Developmental Research Program, which provides research project funding opportunities to be conducted in parallel to the RTCD Program. Last, our Cancer Education Program encourages graduates and undergraduates from across scientific disciplines to pursue careers in the biosciences and provides a pipeline into our RTCD and Developmental Research Programs. The partnership's additional objectives are to expand our established Community Outreach Program to promote cancer awareness and healthy lifestyles among our most underserved populations and to increase minority participation in therapeutic clinical trials. Our Bioethics Shared Resource not only is important in promoting and insuring adherence to bioethical principles, but also addresses important ethical considerations in relationships between majority and minority institutions and between institutions and underserved communities. With continued success, we anticipate that this partnership will provide UABCCC, MSM and TU with an enhanced capability to conduct cancer health disparity research. In summary, we propose to accomplish our objectives through the enhancement of four existing programs, Developmental Research, Research Training and Career Development, Community Outreach, and Cancer Education Programs. The Programs are additionally supported by the Bioethics and Biostatistics Shared Resource.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA118948-05
Application #
7893089
Study Section
Special Emphasis Panel (ZCA1-SRRB-Y (O1))
Program Officer
Ogunbiyi, Peter
Project Start
2005-09-30
Project End
2011-08-31
Budget Start
2010-09-01
Budget End
2011-08-31
Support Year
5
Fiscal Year
2010
Total Cost
$1,059,331
Indirect Cost
Name
University of Alabama Birmingham
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Luo, Yanzhuo; Li, Bingjin; Zhang, Guangxin et al. (2018) Integrated Oncogenomic Profiling of Copy Numbers and Gene Expression in Lung Adenocarcinomas without EGFR Mutations or ALK Fusion. J Cancer 9:1096-1105
Wang, Chiung-Min; Yang, William H; Liu, Runhua et al. (2018) FOXP3 Activates SUMO-Conjugating UBC9 Gene in MCF7 Breast Cancer Cells. Int J Mol Sci 19:
Moore, Justin Xavier; Royston, Kendra J; Langston, Marvin E et al. (2018) Mapping hot spots of breast cancer mortality in the United States: place matters for Blacks and Hispanics. Cancer Causes Control :
Akinyemiju, Tomi; Moore, Justin Xavier; Pisu, Maria et al. (2018) A Prospective Study of Obesity, Metabolic Health, and Cancer Mortality. Obesity (Silver Spring) 26:193-201
Akinyemiju, Tomi; Moore, Justin Xavier; Judd, Suzanne E et al. (2018) Pre-diagnostic biomarkers of metabolic dysregulation and cancer mortality. Oncotarget 9:16099-16109
Piyathilake, Chandrika J; Badiga, Suguna; Borak, Samuel G et al. (2017) A higher degree of expression of DNA methyl transferase 1 in cervical cancer is associated with poor survival outcome. Int J Womens Health 9:413-420
Williams, Samuel K; Braxton, Joanne M; Gosdin, Melissa et al. (2017) Evidence-Based Care for the Elderly: Uses of ""the Grandmother Principle"". J Health Care Poor Underserved 28:7
Gao, Song; Wang, Yicun; Wang, Meng et al. (2017) MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer. Oncotarget 8:41451-41464
Jia, Xu; Shanmugam, Chandrakumar; Paluri, Ravi K et al. (2017) Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer. Oncotarget 8:20198-20212
Zhang, Yifan; Li, Bingjin; Zhang, Xingyi et al. (2017) CD24 is a genetic modifier for risk and progression of prostate cancer. Mol Carcinog 56:641-650

Showing the most recent 10 out of 193 publications